Study of inhibitory effects of CIK on Lewis lung carcinoma

LI Shu-yan,ZHANG Chun-jing,WANG Shu-ying,WU Qi,ZHAO Shou-qi,PEI Chun-ying

DOI: https://doi.org/10.3969/j.issn.1005-8982.2007.21.013

2007-01-01

Abstract:[Objiective] To investigate the inhibitory effects of CIK on the proliferation of Lewis lung carcinoma cell line and the growth of transplanted Lewis lung carcinoma in C57BL/6N mice in vivo. [Methods] CIK cells were induced by culturing PBMC with regular method. The proliferation of Lewis lung carcinoma cells was measured by MTT assay. Ultramicrostructure of Lewis lung carcinoma cells was observed under a transmission electron microscope. Flowcytometric analysis was used to detect cell apoptosis. ultrastructural observation expression of FasL were individually determined by MTT and immunocytochemistry (ICC) analysis. IL-2, IL-4, IFN-r and TNF-αwere tested by ELISA. [Results] Electron microscopic observations showed that CIK cells could induce the lung carcinoma cells to apoptosis. Flow cytometric analysis demonstrated that apoptosis cells of Lewis lung carcinoma increased in CIK group compared with those in the control group. FasL expression on CIK increased. Cytotoxicity was blocked after addition of anti-FasmAb. Level of cytokine in CIK therapy group was higher than that of the control group. [Conclusions] CIK has inhibitory effect on Lewis lung carcinoma cells both in vitro and in vivo. CIK cells can induce the apoptosis of Lewis lung carcinoma cells, and Fas/FasL pathway plays an important role in apoptosis of Lewis lung carcinoma cells by CIK. The CIK therapy is possibly correlated with induction of the activation of the splenic lymphocytes secreting cytokine.